secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001654954-25-006837
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud

Zivo Bioscience shareholders elect directors, ratify auditor, and approve executive compensation at annual meeting
--------------------------------------------------------------------------------

- Elected John B. Payne and Alison A. Cornell as Class III directors with 1,681,190 and 1,681,001 votes for, respectively; broker non-votes 792,911.
- Ratified BDO USA, P.C. as independent auditor for fiscal year 2025 with 2,438,089 votes for, 53,549 against, 15,420 abstain.
- Advisory approval of named executive officer compensation: 1,665,583 for, 48,443 against, 121 abstain; broker non-votes 792,911.
- Total shares present at meeting: 2,507,058 (66.11% of outstanding common stock).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495425006837/0001654954-25-006837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495425006837/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-006837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer